EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic characterization and therapeutic potential of five broad-spectrum lytic bacteriophages against multidrug-resistant avian pathogenic Escherichia coli (APEC)

Tushar Midha iD, Vishakha, Somesh Baranwal iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.03979-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Tushar Midha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Disease Laboratory, Department of Microbiology, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab, India. Hauptthemen laut MEDLINE: Escherichia coli Infections, Escherichia coli, Drug Resistance, Multiple, Bacterial, Phage Therapy. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colibacillosis, caused by avian pathogenic Escherichia coli (APEC), results in substantial economic losses in global poultry production. The emergence of multidrug-resistant (MDR) APEC poses zoonotic risks through horizontal transfer of antimicrobial resistance (AMR) genes. Bacteriophage therapy emerges as a safe alternative to antibiotherapy; however, comprehensive characterization of phages targeting MDR-APEC from diverse geographical regions remains limited. We isolated five lytic bacteriophages from poultry fecal samples collected from five Indian states and characterized them through morphological analysis, physiological stability testing, whole-genome sequencing, and in vivo efficacy assessment. Host range was determined against APEC isolates, and therapeutic potential was validated in the Galleria mellonella infection model. All phages showed Myovirus-like morphology and stability across physiologically relevant temperatures (up to 55°C–70°C) and pH conditions (3–11). Phages were classified as Escherichia phage vB_EcoM_fRPOT1, vB_EcoM_fDMYT1, vB_EcoM_fBSZT1, vB_EcoM_fUAMT1, and vB_EcoM_fPKPT2. Their genome size ranges from 170 to 356 kb, belonging to three distinct genera: Dhakavirus , Gaprivervirus , and Asteriusvirus . Genomic analysis confirmed the absence of antimicrobial resistance, virulence, toxin, or lysogeny genes. Fifty-one APEC strains were isolated, of which 23 (45.1%) were MDR. Individual phages lysed 37%–51% of tested APEC and 17%–39% of MDR strains. Three phages (fBSZT1, fUAMT1, and fPKPT2) significantly improved larval survival to 60%–80% at an MOI of 10 in G. mellonella infection models compared to the untreated control. This study establishes a well-characterized phage bank targeting MDR-APEC strains, providing a foundation for developing phage-based interventions to reduce antibiotic dependency and mitigate AMR transmission risks under the One Health framework. IMPORTANCE The overuse of antibiotics in poultry farming has created a crisis. The multidrug-resistant (MDR) bacteria threaten both animal health and human safety through the food chain. When antibiotics fail, farmers face devastating losses, and resistant bacteria can transfer to humans through consumption or environmental contamination. Bacteriophages offer a practical solution as they kill target bacteria without harming beneficial microbes or leaving chemical residues. Our comprehensive characterization confirms that these five phages are safe and effective as they lack any resistance or toxin genes and rescue 60%–80% of infected larvae. This represents a characterized phage bank targeting the specific resistant strains in Indian poultry. By providing a validated alternative to antibiotics, this work supports sustainable food production while reducing the spread of antimicrobial resistance from farms to humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coli InfectionsEscherichia coliDrug Resistance, Multiple, BacterialPhage TherapyPoultry DiseasesBacteriophagesColiphagesAnimalsHost SpecificityGenome, ViralFecesChickensGenomicsWhole Genome SequencingPoultry

Stichwörter der Autor:innen

Galleria mellonellaOne Healthavian pathogenic Escherichia coli (APEC)bacteriophage therapygenomicsmultidrug resistance (MDR)

Autor:innen und Institutionen

  • Gastrointestinal Disease Laboratory, Department of Microbiology, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab, India.

ORCID-Profile: Tushar Midha, Somesh Baranwal

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Midha, T., Vishakha, & Baranwal, S. (2026). Genomic characterization and therapeutic potential of five broad-spectrum lytic bacteriophages against multidrug-resistant avian pathogenic Escherichia coli (APEC). Microbiology Spectrum. https://doi.org/10.1128/spectrum.03979-25

Vancouver

Midha T, Vishakha, Baranwal S. Genomic characterization and therapeutic potential of five broad-spectrum lytic bacteriophages against multidrug-resistant avian pathogenic Escherichia coli (APEC). Microbiology Spectrum. 2026. doi:10.1128/spectrum.03979-25

BibTeX
@article{Midha2026,
  author = {Midha, Tushar and Vishakha and Baranwal, Somesh},
  title = {Genomic characterization and therapeutic potential of five broad-spectrum lytic bacteriophages against multidrug-resistant avian pathogenic Escherichia coli (APEC)},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.03979-25}
}
Kostenlos starten →